Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / People / Dave Cescon
Person

Dave Cescon

Tracked across 1 events · 6 articles · First seen Aug 17, 2026 · Last active Aug 17, 2026

Sentiment
50
Attention
4
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (1)
4 50
Regulatory
Health Canada approves elinzanetant for breast cancer
Canada — Health Canada has expanded the market authorization of Bayer's elinzanetant (brand name Lynkuet) to treat moderate to severe hot flashes and night sweats in breast cancer patients. The drug was first approved in…
Impact: Medical oncologist who endorsed the approval as helpful; no financial ties to Bayer.
Aug 17, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Dave Cescon live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.